Skip to main content
Top
Published in: BMC Cancer 1/2019

Open Access 01-12-2019 | Breast Cancer | Research article

Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women

Authors: Kai Wang, Guanying Wang, Shangke Huang, Anqi Luo, Xin Jing, Gang Li, Yi Zhou, Xinhan Zhao

Published in: BMC Cancer | Issue 1/2019

Login to get access

Abstract

Background

TIMP-2 gene plays an important role in the development of breast cancer. The present study was conducted to evaluate whether TIMP-2 gene polymorphisms are associated with breast cancer risk in a Han Chinese cohort.

Methods

Six single nucleotide polymorphisms (SNPs) within the TIMP-2 gene in 571 breast cancer and 578 healthy control subjects were genotyped through the Agena MassARRAY. Logistic regression analysis was used to assess the influence of TIMP-2 polymorphisms on breast cancer. Functional annotation of TIMP-2 variants and TIMP-2 expression were analyzed by bioinformatics.

Results

Bioinformatics analysis found that rs4789936 was likely to affect transcription factor binding, motifs, DNase footprint, and DNase peaks; and TIMP-2 was under-expressed in breast cancer, the risk allele of rs4789936 was associated with increased expression of TIMP-2 in peripheral blood samples. Importantly, individuals carrying TIMP-2 rs2277698 T allele have a 19% lower risk of breast cancer than individuals with allele C, providing protection (OR = 0.81, 95%CI = 0.67–0.99, p = 0.041). In the breast cancer patients with c-erb positive and PR positive, when the CC genotype was used as a reference, individuals carrying the TT genotype increased the risk of breast cancer. Haplotype analysis showed “TCC” was associated with a reduced risk of breast cancer (OR = 0.79, 95%CI = 0.63–0.97, p = 0.028).

Conclusion

Our study indicated that TIMP-2 rs2277698 was associated with breast cancer susceptibility.
Literature
1.
go back to reference Wieczorek E, Reszka E, Gromadzinska J, Wasowicz W. Genetic polymorphism of matrix metalloproteinases in breast cancer. Neoplasma. 2012;59(3):237–47.CrossRef Wieczorek E, Reszka E, Gromadzinska J, Wasowicz W. Genetic polymorphism of matrix metalloproteinases in breast cancer. Neoplasma. 2012;59(3):237–47.CrossRef
2.
go back to reference Insua-Rodriguez J, Oskarsson T. The extracellular matrix in breast cancer. Adv Drug Deliv Rev. 2016;97:41–55.CrossRef Insua-Rodriguez J, Oskarsson T. The extracellular matrix in breast cancer. Adv Drug Deliv Rev. 2016;97:41–55.CrossRef
3.
go back to reference Saeed HM, Alanazi MS, Alshahrani O, Parine NR, Alabdulkarim HA, Shalaby MA. Matrix metalloproteinase-2 C(−1306)T promoter polymorphism and breast cancer risk in the Saudi population. Acta Biochim Pol. 2013;60(3):405–9.CrossRef Saeed HM, Alanazi MS, Alshahrani O, Parine NR, Alabdulkarim HA, Shalaby MA. Matrix metalloproteinase-2 C(−1306)T promoter polymorphism and breast cancer risk in the Saudi population. Acta Biochim Pol. 2013;60(3):405–9.CrossRef
4.
go back to reference Kanayama H, Yokota K, Kurokawa Y, Murakami Y, Nishitani M, Kagawa S. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer. 2015;82(7):1359-66.CrossRef Kanayama H, Yokota K, Kurokawa Y, Murakami Y, Nishitani M, Kagawa S. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer. 2015;82(7):1359-66.CrossRef
5.
go back to reference Turpeenniemi-Hujanen T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie. 2005;87(3–4):287–97.CrossRef Turpeenniemi-Hujanen T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie. 2005;87(3–4):287–97.CrossRef
6.
go back to reference Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827–39.CrossRef Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827–39.CrossRef
7.
go back to reference Srivastava P, Lone TA, Kapoor R, Mittal RD. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India. Arch Med Res. 2012;43(2):117–24.CrossRef Srivastava P, Lone TA, Kapoor R, Mittal RD. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India. Arch Med Res. 2012;43(2):117–24.CrossRef
8.
go back to reference Vairaktaris E, Yapijakis C, Yiannopoulos A, Vassiliou S, Serefoglou Z, Vylliotis A, Nkenke E, Derka S, Critselis E, Avgoustidis D, et al. Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans. Oncol Rep. 2007;17(4):963–8.PubMed Vairaktaris E, Yapijakis C, Yiannopoulos A, Vassiliou S, Serefoglou Z, Vylliotis A, Nkenke E, Derka S, Critselis E, Avgoustidis D, et al. Strong association of the tissue inhibitor of metalloproteinase-2 polymorphism with an increased risk of oral squamous cell carcinoma in Europeans. Oncol Rep. 2007;17(4):963–8.PubMed
9.
go back to reference Yaykasli KO, Kayikci MA, Yamak N, Soguktas H, Duzenli S, Arslan AO, Metin A, Kaya E, Hatipoglu OF. Polymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancer. Turk J Med Sci. 2014;44(5):839–43.CrossRef Yaykasli KO, Kayikci MA, Yamak N, Soguktas H, Duzenli S, Arslan AO, Metin A, Kaya E, Hatipoglu OF. Polymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancer. Turk J Med Sci. 2014;44(5):839–43.CrossRef
10.
go back to reference Mikolajczyk-Stecyna J, Korcz A, Gabriel M, Pawlaczyk K, Oszkinis G, Slomski R. Gene polymorphism −418 G/C of tissue inhibitor of metalloproteinases 2 is associated with abdominal aortic aneurysm. J Vasc Surg. 2015;61(5):1114–9.CrossRef Mikolajczyk-Stecyna J, Korcz A, Gabriel M, Pawlaczyk K, Oszkinis G, Slomski R. Gene polymorphism −418 G/C of tissue inhibitor of metalloproteinases 2 is associated with abdominal aortic aneurysm. J Vasc Surg. 2015;61(5):1114–9.CrossRef
11.
go back to reference P OC, Khantapura P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol. 2006;42(3):257–67.CrossRef P OC, Khantapura P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol. 2006;42(3):257–67.CrossRef
12.
go back to reference Zhang DY, Wang J, Zhang GQ, Chu XQ, Zhang JL, Zhou Y. Correlations of MMP-2 and TIMP-2 gene polymorphisms with the risk and prognosis of gastric cancer. Int J Clin Exp Med. 2015;8(11):20391–401.PubMedPubMedCentral Zhang DY, Wang J, Zhang GQ, Chu XQ, Zhang JL, Zhou Y. Correlations of MMP-2 and TIMP-2 gene polymorphisms with the risk and prognosis of gastric cancer. Int J Clin Exp Med. 2015;8(11):20391–401.PubMedPubMedCentral
13.
go back to reference Guo T, Hao H, Zhou L, Zhou F, Yu D. Association of SNPs in the TIMP-2 gene and large artery atherosclerotic stroke in southern Chinese Han population. Oncotarget. 2018;9(4):4698–706.PubMed Guo T, Hao H, Zhou L, Zhou F, Yu D. Association of SNPs in the TIMP-2 gene and large artery atherosclerotic stroke in southern Chinese Han population. Oncotarget. 2018;9(4):4698–706.PubMed
14.
go back to reference Wang K, Zhou Y, Li G, Wen X, Kou Y, Yu J, He H, Zhao Q, Xue F, Wang J, et al. MMP8 and MMP9 gene polymorphisms were associated with breast cancer risk in a Chinese Han population. Sci Rep. 2018;8(1):13422.CrossRef Wang K, Zhou Y, Li G, Wen X, Kou Y, Yu J, He H, Zhao Q, Xue F, Wang J, et al. MMP8 and MMP9 gene polymorphisms were associated with breast cancer risk in a Chinese Han population. Sci Rep. 2018;8(1):13422.CrossRef
15.
go back to reference Jin T, Cao W, Zuo X, Li M, Yang Y, Liang T, Yang H, Zhao X, Yang D. IL-1RN gene polymorphisms are associated with breast cancer risk in a Chinese Han population. The journal of gene medicine. 2017;19(12).CrossRef Jin T, Cao W, Zuo X, Li M, Yang Y, Liang T, Yang H, Zhao X, Yang D. IL-1RN gene polymorphisms are associated with breast cancer risk in a Chinese Han population. The journal of gene medicine. 2017;19(12).CrossRef
16.
go back to reference Peterson NB, Beeghly-Fadiel A, Gao YT, Long J, Cai Q, Shu XO, Zheng W. Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival. Int J Cancer. 2009;125(4):844–50.CrossRef Peterson NB, Beeghly-Fadiel A, Gao YT, Long J, Cai Q, Shu XO, Zheng W. Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival. Int J Cancer. 2009;125(4):844–50.CrossRef
17.
go back to reference Gabriel S, Ziaugra L, Tabbaa D: SNP genotyping using the Sequenom MassARRAY iPLEX platform. Current protocols in human genetics 2009, Chapter 2:Unit 2.12. Gabriel S, Ziaugra L, Tabbaa D: SNP genotyping using the Sequenom MassARRAY iPLEX platform. Current protocols in human genetics 2009, Chapter 2:Unit 2.12.
18.
go back to reference Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39(3):347–51.CrossRef Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, et al. High-throughput oncogene mutation profiling in human cancer. Nat Genet. 2007;39(3):347–51.CrossRef
19.
go back to reference Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790–7.CrossRef Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012;22(9):1790–7.CrossRef
20.
go back to reference Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016;44(D1):D877–81.CrossRef Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016;44(D1):D877–81.CrossRef
21.
go back to reference Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–58.CrossRef Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–58.CrossRef
22.
go back to reference Adamec C. Example of the use of the nonparametric test. Test X2 for comparison of 2 independent examples. Ceskoslovenske zdravotnictvi. 1964;12:613–9.PubMed Adamec C. Example of the use of the nonparametric test. Test X2 for comparison of 2 independent examples. Ceskoslovenske zdravotnictvi. 1964;12:613–9.PubMed
23.
go back to reference Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ. 2000;320(7247):1468.CrossRef Bland JM, Altman DG. Statistics notes. The odds ratio. BMJ. 2000;320(7247):1468.CrossRef
24.
go back to reference Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–5.CrossRef Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–5.CrossRef
25.
go back to reference Remacle A, McCarthy K, Noel A, Maguire T, McDermott E, O'Higgins N, Foidart JM, Duffy MJ. High levels of TIMP-2 correlate with adverse prognosis in breast cancer. Int J Cancer. 2000;89(2):118–21.CrossRef Remacle A, McCarthy K, Noel A, Maguire T, McDermott E, O'Higgins N, Foidart JM, Duffy MJ. High levels of TIMP-2 correlate with adverse prognosis in breast cancer. Int J Cancer. 2000;89(2):118–21.CrossRef
26.
go back to reference Gakiopoulou H, Nakopoulou L, Siatelis A, Mavrommatis I, Panayotopoulou EG, Tsirmpa I, Stravodimos C, Giannopoulos A. Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003;9(15):5573–81. Gakiopoulou H, Nakopoulou L, Siatelis A, Mavrommatis I, Panayotopoulou EG, Tsirmpa I, Stravodimos C, Giannopoulos A. Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003;9(15):5573–81.
27.
go back to reference Chen J, Guo Y, Jin T, Li J, Du J, Cao Y, Wang J. Association of MMPs/TIMPs polymorphism with alcohol-induced osteonecrosis of femoral head in the Chinese Han population; 2016. Chen J, Guo Y, Jin T, Li J, Du J, Cao Y, Wang J. Association of MMPs/TIMPs polymorphism with alcohol-induced osteonecrosis of femoral head in the Chinese Han population; 2016.
28.
go back to reference Kukkonen MK, Tiili E, Vehmas T, Oksa P, Piirila P, Hirvonen A. Association of genes of protease-antiprotease balance pathway to lung function and emphysema subtypes. BMC Pulm Med. 2013;13:36.CrossRef Kukkonen MK, Tiili E, Vehmas T, Oksa P, Piirila P, Hirvonen A. Association of genes of protease-antiprotease balance pathway to lung function and emphysema subtypes. BMC Pulm Med. 2013;13:36.CrossRef
29.
go back to reference Park KS, Kim SJ, Kim KH, Kim JC. Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol. 2011;26(2):391–7.CrossRef Park KS, Kim SJ, Kim KH, Kim JC. Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol. 2011;26(2):391–7.CrossRef
30.
go back to reference An HJ, Ahn EH, Kim JO, Park HS, Ryu CS, Cho SH, Kim JH, Lee WS, Kim NK. Association between tissue inhibitor of metalloproteinase (TIMP) genetic polymorphisms and primary ovarian insufficiency (POI). Maturitas. 2019;120:77–82.CrossRef An HJ, Ahn EH, Kim JO, Park HS, Ryu CS, Cho SH, Kim JH, Lee WS, Kim NK. Association between tissue inhibitor of metalloproteinase (TIMP) genetic polymorphisms and primary ovarian insufficiency (POI). Maturitas. 2019;120:77–82.CrossRef
31.
go back to reference Lee PH, Shatkay H. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res. 2008;36(Database issue):D820–4.PubMed Lee PH, Shatkay H. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res. 2008;36(Database issue):D820–4.PubMed
Metadata
Title
Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women
Authors
Kai Wang
Guanying Wang
Shangke Huang
Anqi Luo
Xin Jing
Gang Li
Yi Zhou
Xinhan Zhao
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2019
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-019-5655-8

Other articles of this Issue 1/2019

BMC Cancer 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine